Psychedelic Therapy Groups Formed Professional Partnership
The organizations have aligned to standardize training and education for practitioners in the emerging therapy field.
Updated on Oct. 5, 2026 in Mental Health
Live Poll
Do you believe professional partnerships between non-profits help ensure higher ethical standards in emerging medical fields?
The Multidisciplinary Association for Psychedelic Studies (MAPS) has partnered with the International Alliance of Psychedelic Therapy Practitioners to bolster clinical standards. This collaboration aims to provide comprehensive training and continuing education for those working in psychedelic-assisted therapy.
Why it matters
The partnership seeks to build the professional infrastructure necessary for the long-term, sustainable development of psychedelic-assisted clinical care. By focusing on education and consultation, the organizations intend to formalize the training requirements for future practitioners.
MAPS, an organization with a history of research dating back to 1986, has secured $150 million in philanthropic funding. The extent to which these combined educational resources will influence clinical outcomes remains under investigation.
The players
Multidisciplinary Association for Psychedelic Studies
A nonprofit research and educational organization focused on developing psychedelic-assisted therapies.
International Alliance of Psychedelic Therapy Practitioners
A professional association established to set standards for those providing psychedelic-assisted care.
Resilient Pharmaceuticals
A company formerly known as MAPS Public Benefit Corporation and Lykos Therapeutics.
The details
The collaboration leverages the existing research framework of MAPS to provide training and clinical consultation. Programs will include scholarship and sponsored-attendance options to broaden access to standardized educational materials for professionals. By integrating clinical consultation into the partnership, the groups aim to create a consistent professional standard for the delivery of psychedelic-assisted therapy.
Timeline
MAPS was founded in 1986.
The International Alliance of Psychedelic Therapy Practitioners was formed in 2023.
The Alliance will begin accepting new members in October 2026.
Health Landscape
This move represents a shift toward consolidating professional infrastructure within the psychedelic-assisted therapy sector. It mirrors the standard trajectory of clinical fields moving from independent research toward formalized, industry-wide practitioner standards.
For patients considering psychedelic-assisted therapy, the standardization of practitioner training may eventually provide more consistency in clinical care. Any questions regarding the credentials or training history of a potential provider should be discussed directly with your physician.
The takeaway
The formalization of professional standards in emerging therapies is a key trend to monitor for patient safety and clinical quality. When seeking specialized therapy, patients should prioritize verifying the current credentials and clinical training of their healthcare providers.
What happens next
The International Alliance of Psychedelic Therapy Practitioners will begin accepting new members starting in October 2026.
Further reading
Learn more about the latest developments in clinical care within our Mental Health section.
Live Poll
Do you believe professional partnerships between non-profits help ensure higher ethical standards in emerging medical fields?
